Skip to content

Clinical trials

Observational Idiopathic Pulmonary Fibrosis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Idiopathic Pulmonary Fibrosis Phase: Observational Clear all

170 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20055
20061
20072
20082
20094
20104
20127
20139
20146
201511
201610
201712
201818
201912
202010
20219
202211
20235
202410
202510
202610

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed88
Recruiting27
Unknown status23
Active, not recruiting11
Not yet recruiting10
Withdrawn5
Terminated3
Enrolling by invitation3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boehringer Ingelheim16
Royal Brompton & Harefield NHS Foundation Trust7
Hoffmann-La Roche4
National Jewish Health4
Seoul National University Hospital4
Assiut University3
Istituto Clinico Humanitas3
National Heart, Lung, and Blood Institute (NHLBI)3
Pulmonary Care and Research Collaborative Limited3
University of Colorado, Denver3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Idiopathic Pulmonary Fibrosis170
Lung Diseases, Interstitial50
Pulmonary Fibrosis21
Pulmonary Disease, Chronic Obstructive13
Sarcoidosis10
Idiopathic Interstitial Pneumonias9
Alveolitis, Extrinsic Allergic8
Connective Tissue Diseases8
Disease6
Lung Diseases5

Trials

Showing 26 to 50 of 170. Each trial links to its page on Pharma Observatory.

70 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.